Healthcare provider profile · identity verified

Samer Bakhos, M.D.

Family Practice · LOCKPORT, LA · NPI 1194997338

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Eliquis	Apixaban	651	35
Levothyroxine Sodium	Levothyroxine Sodium	465	54
Januvia	Sitagliptin Phosphate	425	suppressed
Atorvastatin Calcium	Atorvastatin Calcium	422	60
Furosemide	Furosemide	416	64
Pantoprazole Sodium	Pantoprazole Sodium	369	56
Amlodipine Besylate	Amlodipine Besylate	292	42
Potassium Chloride	Potassium Chloride	291	45
Memantine Hcl	Memantine Hcl	250	29
Rexulti	Brexpiprazole	223	12
Metoprolol Succinate	Metoprolol Succinate	207	32
Rosuvastatin Calcium	Rosuvastatin Calcium	199	25
Xarelto	Rivaroxaban	199	suppressed
Lisinopril	Lisinopril	186	25
Gabapentin	Gabapentin	180	26
Omeprazole	Omeprazole	163	20
Mirtazapine	Mirtazapine	160	24
Sertraline Hcl	Sertraline Hcl	154	22
Myrbetriq	Mirabegron	153	suppressed
Farxiga	Dapagliflozin Propanediol	150	suppressed
Metformin Hcl	Metformin Hcl	139	19
Jardiance	Empagliflozin	135	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	132	17
Tamsulosin Hcl	Tamsulosin Hcl	127	22
Carvedilol	Carvedilol	123	22
Losartan Potassium	Losartan Potassium	122	20
Sucralfate	Sucralfate	121	suppressed
Donepezil Hcl	Donepezil Hcl	119	17
Quetiapine Fumarate	Quetiapine Fumarate	118	21
Tradjenta	Linagliptin	113	suppressed
Spironolactone	Spironolactone	111	17
Trazodone Hcl	Trazodone Hcl	104	13
Clopidogrel	Clopidogrel Bisulfate	103	18
Duloxetine Hcl	Duloxetine Hcl	103	12
Fluoxetine Hcl	Fluoxetine Hcl	102	13
Metoprolol Tartrate	Metoprolol Tartrate	97	16
Doxazosin Mesylate	Doxazosin Mesylate	96	14
Entresto	Sacubitril/Valsartan	96	suppressed
Pravastatin Sodium	Pravastatin Sodium	95	13
Diclofenac Sodium	Diclofenac Sodium	90	16
Famotidine	Famotidine	85	18
Nifedipine Er	Nifedipine	80	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	75	13
Easy Touch Pen Needle	Pen Needle, Diabetic	72	31
Levetiracetam	Levetiracetam	72	suppressed
Clonazepam	Clonazepam	70	12
Simvastatin	Simvastatin	68	suppressed
Hydrochlorothiazide	Hydrochlorothiazide	65	11
Fluticasone Propionate	Fluticasone Propionate	64	12
Tramadol Hcl	Tramadol Hcl	64	17
Amiodarone Hcl	Amiodarone Hcl	63	11
Allopurinol	Allopurinol	62	suppressed
Ondansetron Hcl	Ondansetron Hcl	60	21
Buspirone Hcl	Buspirone Hcl	59	suppressed
Aripiprazole	Aripiprazole	57	suppressed
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	57	30
Carbidopa-Levodopa	Carbidopa/Levodopa	56	suppressed
Latanoprost	Latanoprost	56	suppressed
Ropinirole Hcl	Ropinirole Hcl	56	suppressed
Quviviq	Daridorexant Hcl	54	suppressed
Gemtesa	Vibegron	53	suppressed
Montelukast Sodium	Montelukast Sodium	53	suppressed
Alprazolam	Alprazolam	52	16
Esomeprazole Magnesium	Esomeprazole Magnesium	50	suppressed
Olanzapine	Olanzapine	49	suppressed
Paroxetine Hcl	Paroxetine Hcl	48	suppressed
Zenpep	Lipase/Protease/Amylase	48	suppressed
Hydralazine Hcl	Hydralazine Hcl	46	11
Ezetimibe	Ezetimibe	45	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	43	suppressed
Risperidone	Risperidone	43	suppressed
Linzess	Linaclotide	42	suppressed
Lorazepam	Lorazepam	42	suppressed
Clonidine Hcl	Clonidine Hcl	40	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	40	14
Atenolol	Atenolol	37	suppressed
Bupropion Xl	Bupropion Hcl	37	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	37	33
Lactulose	Lactulose	36	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	36	suppressed
Benztropine Mesylate	Benztropine Mesylate	35	suppressed
Finasteride	Finasteride	35	suppressed
Lidocaine	Lidocaine	35	suppressed
Xifaxan	Rifaximin	35	suppressed
Citalopram Hbr	Citalopram Hydrobromide	34	suppressed
Novolog Flexpen	Insulin Aspart	34	18
Vascepa	Icosapent Ethyl	34	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	34	suppressed
Droplet Pen Needle	Pen Needle, Diabetic	33	11
Glimepiride	Glimepiride	33	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	32	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	32	suppressed
Valsartan	Valsartan	31	suppressed
Meloxicam	Meloxicam	30	suppressed
Irbesartan	Irbesartan	29	suppressed
Prednisone	Prednisone	29	16
Albuterol Sulfate	Albuterol Sulfate	28	suppressed
Midodrine Hcl	Midodrine Hcl	28	suppressed
Ramipril	Ramipril	28	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	27	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	26	suppressed
Levemir Flexpen	Insulin Detemir	26	suppressed
Tizanidine Hcl	Tizanidine Hcl	26	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	25	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	25	suppressed
Propranolol Hcl	Propranolol Hcl	25	suppressed
Alendronate Sodium	Alendronate Sodium	24	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	24	suppressed
Primidone	Primidone	23	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	22	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	22	22
Torsemide	Torsemide	22	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	22	suppressed
Divalproex Sodium	Divalproex Sodium	21	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	21	suppressed
Humalog Kwikpen U-100	Insulin Lispro	21	suppressed
Metolazone	Metolazone	21	suppressed
Brimonidine Tartrate-Timolol	Brimonidine Tartrate/Timolol	20	suppressed
Metformin Hcl Er	Metformin Hcl	20	suppressed
Methocarbamol	Methocarbamol	20	suppressed
Anastrozole	Anastrozole	19	suppressed
Celecoxib	Celecoxib	19	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	19	suppressed
Temazepam	Temazepam	19	suppressed
Colestipol Hcl	Colestipol Hcl	18	suppressed
Ozempic	Semaglutide	18	suppressed
Ranolazine Er	Ranolazine	18	suppressed
Timolol Maleate	Timolol Maleate	18	suppressed
Baclofen	Baclofen	17	suppressed
Spiriva Respimat	Tiotropium Bromide	17	suppressed
Warfarin Sodium	Warfarin Sodium	17	suppressed
Acebutolol Hcl	Acebutolol Hcl	16	suppressed
Combigan	Brimonidine Tartrate/Timolol	16	suppressed
Haloperidol	Haloperidol	16	suppressed
Novofine 32	Pen Needle, Diabetic	16	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	16	suppressed
Clindamycin Hcl	Clindamycin Hcl	15	12
Cyproheptadine Hcl	Cyproheptadine Hcl	15	suppressed
Imipramine Hcl	Imipramine Hcl	15	suppressed
Meclizine Hcl	Meclizine Hcl	15	suppressed
Nexletol	Bempedoic Acid	15	suppressed
Nystatin	Nystatin	15	11
Stiolto Respimat	Tiotropium Br/Olodaterol Hcl	15	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	15	suppressed
Benazepril Hcl	Benazepril Hcl	14	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	14	suppressed
Levofloxacin	Levofloxacin	14	14
Megestrol Acetate	Megestrol Acetate	14	suppressed
Paxlovid (Eua)	Nirmatrelvir/Ritonavir	14	14
Breo Ellipta	Fluticasone/Vilanterol	13	suppressed
Cilostazol	Cilostazol	13	suppressed
Fluconazole	Fluconazole	13	suppressed
Hydrocortisone	Hydrocortisone	13	suppressed
Insulin Aspart Flexpen	Insulin Aspart	13	suppressed
Lidocaine Hcl	Lidocaine Hcl	13	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	13	suppressed
Diazepam	Diazepam	12	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	12	suppressed
Doxepin Hcl	Doxepin Hcl	12	suppressed
Fludrocortisone Acetate	Fludrocortisone Acetate	12	suppressed
Lamotrigine	Lamotrigine	12	suppressed
Levalbuterol Hcl	Levalbuterol Hcl	12	suppressed
Liothyronine Sodium	Liothyronine Sodium	12	suppressed
Nitroglycerin	Nitroglycerin	12	suppressed
Rivastigmine	Rivastigmine	12	suppressed
Trospium Chloride Er	Trospium Chloride	12	suppressed
Amantadine	Amantadine Hcl	11	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	11	11
Atrovent Hfa	Ipratropium Bromide	11	suppressed
Terazosin Hcl	Terazosin Hcl	11	suppressed
Topiramate	Topiramate	11	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	11	suppressed
Vilazodone Hcl	Vilazodone Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error